- Home
- UAN vs ABCL Comparison
UAN vs ABCL Comparison
Compare UAN & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UAN
- ABCL
- Stock Information
- Founded
- UAN 2007
- ABCL 2012
- Country
- UAN United States
- ABCL Canada
- Employees
- UAN N/A
- ABCL N/A
- Industry
- UAN Agricultural Chemicals
- ABCL Biotechnology: Pharmaceutical Preparations
- Sector
- UAN Industrials
- ABCL Health Care
- Exchange
- UAN Nasdaq
- ABCL Nasdaq
- Market Cap
- UAN 773.6M
- ABCL 818.2M
- IPO Year
- UAN 2011
- ABCL 2020
- Fundamental
- Price
- UAN $74.44
- ABCL $2.42
- Analyst Decision
- UAN
- ABCL Buy
- Analyst Count
- UAN 0
- ABCL 3
- Target Price
- UAN N/A
- ABCL $7.50
- AVG Volume (30 Days)
- UAN 35.3K
- ABCL 4.1M
- Earning Date
- UAN 04-28-2025
- ABCL 05-08-2025
- Dividend Yield
- UAN 9.08%
- ABCL N/A
- EPS Growth
- UAN N/A
- ABCL N/A
- EPS
- UAN 5.76
- ABCL N/A
- Revenue
- UAN $525,323,999.00
- ABCL $28,833,000.00
- Revenue This Year
- UAN N/A
- ABCL N/A
- Revenue Next Year
- UAN N/A
- ABCL $27.77
- P/E Ratio
- UAN $12.92
- ABCL N/A
- Revenue Growth
- UAN N/A
- ABCL N/A
- 52 Week Low
- UAN $62.94
- ABCL $1.89
- 52 Week High
- UAN $88.94
- ABCL $4.34
- Technical
- Relative Strength Index (RSI)
- UAN 52.91
- ABCL 52.58
- Support Level
- UAN $66.00
- ABCL $1.89
- Resistance Level
- UAN $74.95
- ABCL $2.53
- Average True Range (ATR)
- UAN 3.15
- ABCL 0.19
- MACD
- UAN 0.42
- ABCL 0.05
- Stochastic Oscillator
- UAN 79.24
- ABCL 82.79
About UAN CVR Partners LP Common Units representing Limited Partner Interests
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.
About ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.